Curcumin exerts antinociceptive effects in a mouse model of neuropathic pain: Descending monoamine system and opioid receptors are differentially involved
Authors:
- Xin ZhaoXZXin Zhao
- Ying XuYXYing Xu
- Qing ZhaoQZQing Zhao
- Chang-Rui ChenCCChang-Rui Chen
- Ai-Ming LiuALAi-Ming Liu
- Zhi-Li HuangZhi-Li Huang
- 1 February 2012
- journal article
- research article
- Published by Elsevier in Neuropharmacology
- Vol. 62 (2) , 843-854
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revisionEuropean Journal of Neurology, 2010
- Curcumin improves sclerosing cholangitis in Mdr2 −/− mice by inhibition of cholangiocyte inflammatory response and portal myofibroblast proliferationGut, 2010
- Antidepressant treatment of neuropathic pain: looking for the mechanismFuture Neurology, 2009
- From Antidepressant Drugs to Beta-Mimetics: Preclinical Insights on Potential New Treatments for Neuropathic PainRecent Patents on CNS Drug Discovery, 2009
- Chronic, but not acute, tricyclic antidepressant treatment alleviates neuropathic allodynia after sciatic nerve cuffing in miceEuropean journal of pain, 2008
- Delta-Opioid Receptors Are Critical for Tricyclic Antidepressant Treatment of Neuropathic AllodyniaBiological Psychiatry, 2008
- Role of spinal 5‐HT1A receptors in morphine analgesia and tolerance in ratsEuropean journal of pain, 2004
- In the formalin model of tonic nociceptive pain, 8-OH-DPAT produces 5-HT1A receptor-mediated, behaviorally specific analgesiaEuropean Journal of Pharmacology, 2001
- A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in manPain, 1988
- Lack of analgesic effect of opioids on neuropathic and idiopathic forms of painPain, 1988